LEOPARD Prospective Validation Cohort 1 | MicrobiomeTrials← Back to trialsNCT06723275
LEOPARD Prospective Validation Cohort 1
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-07Est. Completion: 2028-07-07
Enrollment target: 630 participants Locations- Department of Gastroenterology and Hepatology Universitair Ziekenhuis Gent, Ghent, Belgium, Belgium
- Beaujon Hospital, Department of Hepatology, Clichy, France, France
- Hospital Henri Mondor, Department of Hepatology, Créteil, France, France
- St Eloi Hospital, Department of Hepato-gastro-enterology,, Montpellier, France, France
- Hospital La Pitié Salpêtrière, Department of Hepato-gastro-enterology, Paris, France, France
- Universitätsklinikum Schleswig - Holstein | UKSH · Transplantation Medicine, Kiel, Germany, Germany
- Italian National Transplant Center, Roma, Italy, Italy
- Center for Liver Tumors Leiden of the Leiden University Medical Center (LUMC), Leiden, Netherlands, Netherlands
Other microbiome trials you might be interested in
PBC
Primary biliary cholangitis (PBC) is a chronic autoimmune intrahepatic cholestatic liver disease characterized by progre…
Beijing, ChinaEst. completion Jul 1, 2027
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing CholangitisHepato-cellular Carcinoma
Intro:
The present clinical research protocol is part of the LEOPARD European project (Grant n° 101080964 Horizon Europ…
Vienna, AustriaEst. completion Mar 2028
Recruiting
The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectiv…
Indianapolis, United StatesEst. completion Dec 31, 2026